Home » Newsletters » BioWorld Science

BioWorld Science

March 23, 2017

View Archived Issues

Lin Bioscience licenses microtubule-targeting agent for brain cancer from University of Sydney

FDA accepts IND for phase I trials of TX-803 for colorectal cancer

Galapagos begins phase I study of cystic fibrosis potentiator GLPG-3067 under AbbVie collaboration

Fixed-dose combination tablets containing ertugliflozin show promise for type 2 diabetes

Preliminary results from malignant pleural mesothelioma cohort of KEYNOTE-028 study

Intec initiates phase I trial of AP-CBD/THC

FDA grants fast track designation to SHP-655 for hereditary thrombotic thrombocytopenic purpura

FDA clears Akashi to resume clinical development of HT-100

FDA grants orphan drug designation to avacopan for C3 glomerulopathy

Promising phase III data presented for alirocumab at ACC

Aveo initiates phase I/II trial of tivozanib and nivolumab in renal cell carcinoma

Achillion Pharmaceuticals patents complement factor D inhibitors

Eli Lilly and Company discloses new histone-lysine N-methyltransferase EZH2 inhibitors

Bayer Pharma discovers coagulation factor XIa and kallikrein inhibitors

Lilly initiates phase I trial of LY-3192767 in healthy subjects

Shenzhen Qingyaqirui Bio-Tech identifies new conjugates of memantine and arctigenin

Danish clearance for Oncology Venture's study of APO-010 in multiple myeloma

HitGen announces research collaboration with Merck & Co.

Bristol-Myers Squibb divulgues myeloperoxidase and/or eosinophil peroxidase inhibitors

FDA grants orphan drug designation for Toleranzia's TOL-2

Cue Biopharma selects lead candidate Cue-101 targeting HPV-associated cancers

Aprea collaborates with Memorial Sloan Kettering to study p53 reactivation by APR-246

Sunesis submits responses to EMA for vosaroxin MAA review

Alexion seeks Japanese approval of Soliris in refractory AChR-positive generalized myasthenia gravis

Phase II seizure data on UX-007 in patients with glucose transporter type-1 deficiency syndrome

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...